Breaking Down Merit Medical Systems: 4 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
Merit Medical Systems (NASDAQ:MMSI) has seen varied analyst opinions over the past three months, with recent updates showing a positive shift in price targets. The average 12-month price target has risen to $92.75, up 12.19% from $82.67. Analysts from B of A Securities, Raymond James, Piper Sandler, and Canaccord Genuity have updated their ratings and price targets, reflecting optimism about the company's performance. Merit Medical Systems, a medical equipment company, has shown a revenue growth of 9.77% and a net margin of 8.2%, outperforming industry standards.
February 07, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems has received updated analyst ratings and price targets, indicating a positive outlook on its financial performance and market position. The average 12-month price target has increased to $92.75, reflecting a 12.19% rise from the previous target.
The increase in the average price target for MMSI, along with positive ratings from analysts, suggests a bullish outlook for the stock. The company's reported revenue growth and strong financial metrics such as net margin and ROE further support this positive sentiment. Given these factors, the stock is likely to experience upward momentum in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100